Cancer remains one of the most challenging health issues worldwide. Current therapies like chemotherapy, radiation, and surgery often come with significant side effects (off-target effects) and limited effectiveness. To address these limitations, my project proposes leveraging synthetic genetic pathways for cancer therapy. This project capitalizes on the processes involved in DNA damage response to create a targeted and low-cytotoxicity approach to combat cancer.